Interleukin-1 receptor antagonists appear to have a role to play in treating inflammatory diseases

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1255, 2000-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restenosis and Inflammatory Diseases

Current Pharmaceutical Design, Vol. 9, Iss. 28, 2003-01 ,pp. : 2349-2365

Bentham Science Publishers

Access to resources Recommend Favorite

A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases

By Arulkumaran Nishkantha Unwin Robert J Tam Frederick WK

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 7, 2011-07 ,pp. : 897-915

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-8 receptor antagonists

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 4, 1998-04 ,pp. : 471-473

Informa Healthcare

Access to resources Recommend Favorite

Hypertension guidelines: angiotensin II receptor antagonists have a role

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 287, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Interleukin-1 antagonists for diabetes

By Mandrup-Poulsen Thomas

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 8, 2013-08 ,pp. : 965-979

Informa Healthcare

Access to resources Recommend Favorite